Site içinde arama yapın | Lifesone

Harshasharma Harshasharma bir ses eklendi Autres
2025-09-30 08:42:21

Lung Cancer Therapeutics Market: Driving Innovations in Targeted and Immunotherapy Solutions
The lung cancer therapeutics market is witnessing rapid advancements in targeted therapies, immuno-oncology, and personalized medicine. Increasing prevalence of lung cancer and growing investments in biotechnology are fueling significant market growth. Get a full overview of market dynamics, forecasts, and trends. Download the complete Display Market...

0 Yorumlar 0 hisse senetleri 292 Views 0 önizleme

Please log in to like, share and comment!
Sophia Sanjay bir ses eklendi Histoire
2025-11-12 06:16:00

Merck, Roche, AstraZeneca Dominate Lung Cancer Therapeutics: Biosimilars and Niche Innovators Challenge $65B Market by 2030
The Lung Cancer Therapeutics Market, valued at $35 billion in 2023 and projected to reach $65 billion by 2030, is dominated by pharmaceutical giants Merck, Roche, and AstraZeneca. These firms leverage proprietary pipelines, global distribution, and strong clinician trust to maintain leadership, but emerging biotechs and biosimilars are eroding their monopoly, particularly in underserved...

0 Yorumlar 0 hisse senetleri 69 Views 0 önizleme

Please log in to like, share and comment!

Lifesone https://lifesone.com